Treatment
Treatment clinical trials
We’re tracking 8,469 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07118241RecruitingPhase 2
Testing a new eye drop for Sjögren's dry eye
This trial tests a new eye drop made from a natural protein (rhPRG4) to see if it safely and effectively relieves dry eye symptoms in people with Sjögren's syndrome. You'll be randomly assigned to receive the study drop or a placebo (inactive) drop for several weeks.
Sydney, New South WalesAges 18–80 - NCT07118254RecruitingPhase 2
Eye drops for dry eye from graft-versus-host disease
This study tests whether a new eye drop (rhPRG4) can safely reduce dry eye symptoms caused by graft-versus-host disease (GVHD). It compares the active drops to an inactive placebo to see if they provide better relief.
Sydney, New South WalesAges 18–75 - NCT07118631Recruiting
Emergency surgery for bleeding brain blood vessel malformation
This study tests emergency surgery for patients with bleeding from a brain blood vessel malformation (AVM). It aims to see if urgent surgery can help people with this type of stroke.
BeijingAges 18–70 - NCT07118813Recruiting
AI predicts kidney cancer surgery outcomes
This trial uses artificial intelligence to read CT scans and predict how well kidney cancer patients will do after surgery. It aims to help doctors plan better treatment for you.
Wuhan, HubeiAges 18 years+ - NCT07119372RecruitingPhase 3
New drug for anemia from kidney disease on dialysis
This trial tests a new drug called BCD-131 (a biosimilar to Mircera) for treating anemia in people with kidney disease on dialysis. It compares the new drug to the standard treatment to see if it works just as well and is safe.
MinskAges 18–75 - NCT07119840Recruiting
Listerine vs. chlorhexidine mouthwash during braces
This trial compares two common mouthwashes (Listerine and chlorhexidine) to see which works better for keeping your teeth and gums healthy while you have braces. If you are getting braces, you can join to help find out which rinse helps prevent plaque and gum problems.
Swāt, KPKAges 13–40 - NCT07120633Recruiting
CAR-T cell therapy plus BTK inhibitor for high-risk CLL/SLL
This trial tests a new approach for people newly diagnosed with high-risk CLL or SLL. It combines your own immune cells (CAR-T cells) with a targeted pill (BTK inhibitor) to try to attack the cancer more effectively. It may be an option if you have certain high-risk genetic features and haven't had prior chemotherapy.
Xuzhou, JiangsuAges 18 years+ - NCT07120659Recruiting
Comparing vacuum and tactile massage for chronic neck pain
This study compares two types of massage (vacuum massage and tactile massage) to see which one works better for people with long-term neck pain. If you have had neck pain for at least 3 months, you may be able to join.
Tromsø, TromsAges 21–75 - NCT07120867Recruiting
Pleural pressure measurement in malignant pleural effusion
This trial tests a procedure called pleural manometry, which measures pressure in the chest during fluid drainage, to see if it helps doctors better assess and treat malignant pleural effusion (fluid buildup around the lung caused by cancer). The goal is to improve symptom relief and treatment decisions.
BarcelonaAges 18 years+ - NCT07121270Recruiting
Sleep treatment after trauma in the ER
This study tests a sleep-focused treatment for people who have experienced a violent trauma (like an assault) in the past few days and are at risk for mental health problems. The goal is to help improve sleep and reduce distress after a traumatic event.
Detroit, MichiganAges 18 years+ - NCT07121556Recruiting
Fat tissue vs fat tissue plus gel for knee osteoarthritis
This trial compares two injections for knee arthritis: one uses your own fat tissue, the other adds a lubricating gel. Researchers want to see if the combination helps pain and function more than fat tissue alone.
BolognaAges 18–75 - NCT07121595RecruitingPhase 2
Personalized neck radiation for mouth cancer with sentinel node biopsy
This study tests whether a personalized approach to radiation therapy after surgery, guided by a special lymph node biopsy (sentinel node biopsy), can effectively treat mouth cancer while reducing side effects. It is for people whose cancer is on one side of the mouth and has not spread to the other side of the neck or beyond.
Ann Arbor, MichiganAges 18 years+ - NCT07121712Recruiting
Brain Stimulation for Generalized Anxiety Disorder
This study tests a non-invasive brain stimulation technique (cTBS) to treat Generalized Anxiety Disorder. You will receive navigated stimulation sessions, and no surgery or medication is used.
Hefei, AnhuiAges 18–60 - NCT07122024RecruitingPhase 4
Testing a dual therapy for H. pylori treatment
This trial tests a two-drug treatment (keverprazan and amoxicillin) for people who have H. pylori and have not been treated for it before. The goal is to see if this newer combination works well and is safe.
Hangzhou, ZhejiangAges 18–65 - NCT07122089RecruitingPhase 2
SIRT plus immunotherapy for liver cancer with portal vein clot
This trial tests a two-step approach for liver cancer that has spread into the portal vein. First, you receive internal radiation (SIRT) to shrink the tumor, followed by immunotherapy drugs (durvalumab with or without tremelimumab) to help your immune system fight the cancer. The goal is to see if this combination is safe and effective.
GrenobleAges 18 years+ - NCT07122401RecruitingPhase 3
Study of MT1013 for dialysis patients with high parathyroid hormone
This trial tests a new medicine called MT1013 for people with secondary hyperparathyroidism who are on dialysis. It may help control high parathyroid hormone levels when current treatments are not enough.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07122895RecruitingPhase 2
NMDA enhancer for negative symptoms in schizophrenia
This study tests whether a medication that boosts brain NMDA receptors can improve negative symptoms in schizophrenia, and looks at differences between men and women. It is for people with stable schizophrenia who still have mostly flat mood or low motivation.
TaichungAges 20–65 - NCT07123129RecruitingPhase 1
Study of SHR-7782 for advanced solid tumors
This trial tests a new drug called SHR-7782 for people with advanced cancers that have not responded to other treatments. It aims to see if the drug is safe and can shrink tumors.
Beijing, Beijing MunicipalityAges 18–75 - NCT07123181Recruiting
Oregano and basil for unstable angina
This trial tests if eating oregano and basil leaves can help people with unstable angina, a type of chest pain from heart disease. It looks for improvements in heart health without using strong medications.
Tehran, Tehran ProvinceAges 30–75 - NCT07123233Recruiting
Cognitive behavioral treatment for chronic face and mouth pain
This trial tests a new cognitive-behavioral therapy (a type of talk therapy) for people with chronic orofacial pain – pain in the face, mouth, or jaw that has lasted for months. The goal is to learn skills to help manage pain and improve quality of life.
MilanAges 18–70 - NCT07123519RecruitingPhase 1
YTS109 cell therapy for hard-to-treat autoimmune diseases
This trial tests a new cell therapy called YTS109 for people with certain severe autoimmune diseases that have not responded to standard treatments, such as lupus, Sjögren's syndrome, systemic sclerosis, inflammatory myopathy, vasculitis, and antiphospholipid syndrome. The goal is to see if it can safely reduce disease activity.
TianjinAges 18–65 - NCT07123727RecruitingPhase 2
Testing Anktiva for long COVID symptoms
This study tests if the drug Anktiva can help people with long COVID. To join, you must have had at least one confirmed COVID-19 infection and now have lasting symptoms that started or got worse after that infection.
El Segundo, CaliforniaAges 18–70 - NCT07123987Recruiting
Ear nerve stimulation for post-shingles pain
This study tests a gentle, non-invasive device that stimulates a nerve in your ear to see if it can reduce lingering pain after shingles. It may be a good option if you have had persistent nerve pain for at least 3 months.
Cairo, Giza GovernorateAges 35–65 - NCT07124078RecruitingPhase 2
Study of axatilimab vs. best available therapy for chronic GVHD in children
This trial tests a new drug called axatilimab against the best available standard treatments for children with chronic graft-versus-host disease (cGVHD) that has not responded to at least two prior treatments. It aims to find a better option for managing this condition.
Duarte, CaliforniaAges 2–17
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,469 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.